Even after the best treatment, ependymomas can regrow or recur.

There is no way to predict which patients are more likely to have tumor recurrence. For this reason, routine check-ups and MRIs are highly recommended.  Most commonly, the regrowth occurs in the same spot as the first tumor. But it is possible for the tumor to grow somewhere else within the central nervous system. The time from treatment to tumor regrowth can be varied.  Often patients are tumor-free for years before testing shows new tumor growth.

Patients who have previously received radiation therapy may not be able to recieve addtional radiation. Instead, surgery and chemotherapy will be the most viable treatment options. Remember, you are not obligated to undergo treatment at the same facility as your first time. Be sure to do research and be aware of your options. We encourage you to consider the various CERN Centers that offer expertise on ependymoma.

If you have learned of a recurrence of ependymoma, try not to be overly discouraged. After receiving the diagnosis and accepting your situation, you can begin to focus on making treatment decisions and start on your road toward recovery. Talk with your doctor about all options. This is a common time when clinical trials are considered. Clinical trials evaluate the safety and effectiveness of investigational cancer therapies. All standard treatments are a result of past clinical trials.

Discuss your concerns, ask questions and connect with others who might be going through what you are. You can even connect with CERN members and others by following us on Facebook and Twitter.

Looking for ependymoma treatment centers?

At the CERN Foundation, we encourage all ependymoma patients to seek a medical opinion with neuro-oncologists that have experience with this disease.

Be Referred

Stay Informed with the CERN Newsletter

The CERN Foundation is committed to informing you with the latest ependymoma news and research. Join our mailing list for monthly updates. View all newsletters